Company / Net Income
CAPRICOR THERAPEUTICS, INC. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$105.0M
FY2025
5-year range
-$105.0M / -$20.0M
FY2021-FY2025
Trend
-159.6%
vs FY2024
Sector context
#111 of 216
Health Care
What the data says
At -$105M, CAPRICOR THERAPEUTICS, INC.'s net income ranks #111 of 216 in the Health Care sector. Net Income has fluctuated over the past 10 years, ranging from -$105M in FY2025 to $2M in FY2017.
Based on SEC 10-K filings.
-$105M in FY2025.
Declined from -$22M to -$105M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#111 of 216 in Health CareTop 51% of 216This company -$105.0M Sector average $454.3M
▼
-123.1% below sector average
Key checks
Key Insights
- In FY2025, net income decreased 159.6% year-over-year.
- Ranks #111 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$105.0M | -159.6% |
| FY2024 | -$40.5M | -81.6% |
| FY2023 | -$22.3M | +23.2% |
| FY2022 | -$29.0M | -44.9% |
| FY2021 | -$20.0M | -46.6% |
| FY2020 | -$13.7M | +10.1% |
| FY2019 | -$15.2M | +0.0% |
| FY2018 | -$15.2M | -724.8% |
| FY2017 | $2.4M | +112.9% |
| FY2016 | -$18.8M | -46.3% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026